Brightsurf Science News & Current Events

September 19, 2015
A cost-effective alternative for treating staphylococcal bloodstream infections
Research comparing clinical outcomes between patients receiving nafcillin and cefazolin for treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia shows that overall treatment failure rate among patients receiving cefazolin was no worse than nafcillin, and significantly fewer adverse effects were documented for those receiving cefazolin.

DNA sequencing to improve treatment of urinary infections
Urinary tract infections could be treated more quickly and efficiently using a DNA sequencing device the size of a USB stick -- according to research from the University of East Anglia.

Silicone vaginal rings deliver antiviral drugs, protect women against HIV
Researchers at University Jean Monnet of Saint-Etienne, France have succeeded in developing a vaginal silicone ring that delivers molecules that act on both HIV and herpes virus.

Rotavirus and pneumococcal conjugate vaccines reduce pediatric hospital burden
Researchers show that the introduction of both pneumococcal conjugate vaccines and rotavirus vaccines led to the rapid and dramatic reduction in hospital burden of both winter diarrhea and respiratory infections within <5 years post introduction of the vaccines.

Phase 3 women-only HIV study sheds light on safe and effective antiretroviral treatments
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.